1. Recent Advances in the Emerging Therapeutic Strategies for Diabetic Kidney Diseases
   Wei Huang et al, 2022, International Journal of Molecular Sciences CrossRef
2. Apelin-13: A Protective Role in Vascular Diseases
   Guang-Gui Zeng et al, 2024, Current Problems in Cardiology CrossRef
3. The effects of apelin-13 against cisplatin-induced nephrotoxicity in rats
   Atilla Topcu et al, 2023, Drug and Chemical Toxicology CrossRef
4. Beneficial effects of Apelin-13 on metabolic diseases and exercise
   Ruiming Wen et al, 2023, Frontiers in Endocrinology CrossRef
5. Apelin‑13 reduces high glucose‑induced mitochondrial dysfunction in cochlear hair cells by inhibiting endoplasmic reticulum stress
   Zhiqiang Huo et al, 2024, Experimental and Therapeutic Medicine CrossRef
6. Expression of apelin‑13 and its negative correlation with TGF‑β1 in patients with diabetic kidney disease
   Qi Wang et al, 2024, Experimental and Therapeutic Medicine CrossRef
7. Apelin pathway in cardiovascular, kidney, and metabolic diseases: Therapeutic role of apelin analogs and apelin receptor agonists
   Amanda A. de Oliveira et al, 2022, Peptides CrossRef
8. Taurine Ameliorates Apoptosis via AKT Pathway in the Kidney of Diabetic Rats
   Shuangyue Li et al, 2022, Taurine 12 CrossRef
9. Nrf2 signaling in diabetic nephropathy, cardiomyopathy and neuropathy: Therapeutic targeting, challenges and future prospective
   Mehrdad Hashemi et al, 2023, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
10. Effects of conditioned media derived from human Wharton’s jelly mesenchymal stem cells on diabetic nephropathy and hepatopathy via modulating TGF-β and apelin signaling pathways in male rats
    Zeinab Karimi et al, 2024, BMC Endocrine Disorders CrossRef
11. The Role of Apelin–APJ System in Diabetes and Obesity
    Cheng Li et al, 2022, Frontiers in Endocrinology CrossRef
12. Evaluation of Apelin-13 levels in patients with diabetic nephropathy
    Gamze İçen et al, 2022, International Urology and Nephrology CrossRef